Bando subsidiary Aimedic MMT has launched on April 1 an absorbable bone regeneration material marketed as e=Bone. The material uses the results of a research project for the development of artificial bones in industry-academia collaboration with the Department of Orthopedic Surgery, Osaka University Graduate School of Medicine, and the Department of Materials Production Science, Osaka University Graduate School of Engineering....
Please subscribe to read the full story.Subscribe
Already a member? Log in here
